Abstract | BACKGROUND: OBJECTIVE: To assess rupatadine efficacy in preventing reactions to cold challenge in patients with ACU. METHODS: A crossover, randomized, double-blind, placebo-controlled study in which 21 patients with ACU received rupatadine, 20 mg/d, or placebo for 1 week each is presented. The main outcome was the critical stimulation time threshold (CSTT) determined by ice cube challenge. Secondary outcomes included CSTT and the critical temperature threshold assessed by a cold provocation device (TempTest 3.0), as well as scores for wheal reactions, pruritus, burning sensations, and subjective complaints after cold challenge. RESULTS: After rupatadine treatment, 11 (52%) of 21 patients exhibited a complete response (ie, no urticaria lesions after ice cube provocation). A significant improvement in CSTT compared with placebo was observed after ice cube and TempTest 3.0 challenge (P = .03 and P = .004, respectively). A significant reduction of critical temperature threshold (P < .001) and reduced scores for cold provocation-induced wheal reactions (P = .01), pruritus (P = .005), burning sensation (P = .03), and subjective complaints (P = .03) after rupatadine treatment were also found. Mild fatigue (n = 4), somnolence (n = 1), and moderate headache (n = 1) were reported during active treatment. CONCLUSION:
Rupatadine, 20 mg/d, shows high efficacy and is well tolerated in the treatment of ACU symptoms.
|
Authors | Martin Metz, Elisabeth Scholz, Marta Ferrán, Iñaki Izquierdo, Ana Giménez-Arnau, Marcus Maurer |
Journal | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
(Ann Allergy Asthma Immunol)
Vol. 104
Issue 1
Pg. 86-92
(Jan 2010)
ISSN: 1081-1206 [Print] United States |
PMID | 20143651
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Histamine Antagonists
- Platelet Activating Factor
- rupatadine
- Cyproheptadine
|
Topics |
- Adult
- Cold Temperature
- Cyproheptadine
(administration & dosage, adverse effects, analogs & derivatives)
- Double-Blind Method
- Environmental Exposure
- Female
- Histamine Antagonists
(administration & dosage, adverse effects)
- Humans
- Male
- Middle Aged
- Platelet Activating Factor
(antagonists & inhibitors)
- Pruritus
- Treatment Outcome
- Urticaria
(drug therapy, physiopathology)
|